[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPH04253974A - Sulfonylurea compound, its production and herbicide containing the same - Google Patents

Sulfonylurea compound, its production and herbicide containing the same

Info

Publication number
JPH04253974A
JPH04253974A JP10062891A JP10062891A JPH04253974A JP H04253974 A JPH04253974 A JP H04253974A JP 10062891 A JP10062891 A JP 10062891A JP 10062891 A JP10062891 A JP 10062891A JP H04253974 A JPH04253974 A JP H04253974A
Authority
JP
Japan
Prior art keywords
group
optionally substituted
alkyl
reaction
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10062891A
Other languages
Japanese (ja)
Inventor
Nobuyuki Sakashita
坂下 信行
Toshio Nakajima
俊雄 中島
Shigeo Murai
重夫 村井
Tsunezou Yoshida
吉田 常象
Yuji Nakamura
裕治 中村
Masahiko Sawaki
雅彦 澤木
Shoichi Motosawa
本澤 彰一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Priority to JP10062891A priority Critical patent/JPH04253974A/en
Publication of JPH04253974A publication Critical patent/JPH04253974A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)

Abstract

PURPOSE:To provide a new compound useful as an active component of a herbicide exhibiting broad herbicidal spectrum at low rate of application. CONSTITUTION:The compound of formula I (R<1> is cycloalkyl, alkoxyalkyl, phenyl, pyridyl, thienyl, furyl, pyrazolyl or pyrazinyl; R<2> is alkyl, haloalkyl, etc.; R<3> is H, halogen, alkyl, etc.; X and Y are halogen, alkyl, alkoxy, etc.; A is =CH- or =N-), e.g. 4-trifluoromethyl-N-[6-[[(4,6-dimethoxypyrimidin-2-yl) aminocarbonyl]aminosulfonyl]pyridin-2-yl]-N-methylbenzamide. The compound can be produced by reacting a compound of formula II [Z<1> is -NH2, -NCO or -NHCO2R<4> (R<4> is alkyl or aryl)] with a compound of formula III (Z<2> is -NH2 when Z<1> is -NCO or -NHCO2R<4> and Z<2> is -NCO or -NHCO2R<4> when Z<1> is -NH2).

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、新規なスルホニル尿素
系化合物又はそれらの塩、それらの製造方法及びそれら
を含有する除草剤に関する。
TECHNICAL FIELD The present invention relates to novel sulfonylurea compounds or salts thereof, methods for producing them, and herbicides containing them.

【0002】0002

【従来技術】米国特許第4,946,494号公報には
除草剤の有効成分として有用なピリジンスルホニル尿素
誘導体が記載されているが、本発明化合物とはスルホニ
ル尿素基が直接結合しているピリジン環の6位の置換基
において構造が異なる。
[Prior Art] U.S. Pat. No. 4,946,494 describes pyridine sulfonylurea derivatives useful as active ingredients of herbicides. The structure differs in the substituent at the 6-position of the ring.

【0003】0003

【発明の構成】本発明は、後記一般式(I)で表わされ
るスルホニル尿素系化合物又はそれらの塩、それらの製
造方法及びそれらを含有する除草剤、さらには該化合物
を製造するための中間体に関する。 一般式(I)
[Structure of the Invention] The present invention relates to sulfonylurea compounds represented by the general formula (I) below or salts thereof, methods for producing them, herbicides containing them, and intermediates for producing the compounds. Regarding. General formula (I)

【化1】 (式中、R1はシクロアルキル基、アルコキシアルキル
基、置換されてもよいフェニル基、置換されてもよいピ
リジル基、置換されてもよいチエニル基、置換されても
よいフリル基、置換されてもよいピラゾリル基又は置換
されてもよいピラジニル基であり、R2はアルキル基、
ハロアルキル基、シクロアルキル基、フェニル基又はベ
ンジル基であり、R3は水素原子、ハロゲン原子、アル
キル基又はハロアルキル基であり、X及びYは各々独立
してハロゲン原子、アルキル基、アルコキシ基又はハロ
アルコキシ基であり、Aは=CH−又は=N−である)
embedded image (wherein R1 is a cycloalkyl group, an alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted thienyl group, an optionally substituted furyl group, an optionally substituted pyrazolyl group or an optionally substituted pyrazinyl group, R2 is an alkyl group,
A haloalkyl group, a cycloalkyl group, a phenyl group, or a benzyl group, R3 is a hydrogen atom, a halogen atom, an alkyl group, or a haloalkyl group, and X and Y are each independently a halogen atom, an alkyl group, an alkoxy group, or a haloalkoxy and A is =CH- or =N-)

【0004】一般式(I)中、R1に含まれる置換され
てもよいフェニル基、置換されてもよいピリジル基、置
換されてもよいチエニル基、置換されてもよいフリル基
、置換されてもよいピラゾリル基及び置換されてもよい
ピラジニル基の置換基としては、例えばハロゲン原子、
アルキル基、ハロアルキル基、アルコキシ基、−NO2
基、−CN基、−CO2R5基、−SO2CH3基など
が挙げられ、R5は水素原子又はアルキル基である。ま
た、それら置換基の置換数は1又は2以上であってもよ
く、置換数が2以上の場合、置換基の種類は同じでも異
なっていてもよい。
In the general formula (I), an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted thienyl group, an optionally substituted furyl group, an optionally substituted furyl group, and an optionally substituted furyl group included in R1 Good examples of substituents for the pyrazolyl group and the optionally substituted pyrazinyl group include halogen atoms,
Alkyl group, haloalkyl group, alkoxy group, -NO2
group, -CN group, -CO2R5 group, -SO2CH3 group, etc., and R5 is a hydrogen atom or an alkyl group. Moreover, the number of substitutions of these substituents may be 1 or 2 or more, and when the number of substitutions is 2 or more, the types of substituents may be the same or different.

【0005】一般式(I)中、R1、R2、R3、R5
、X及びYに含まれるアルキル基並びにアルキル部分と
しては炭素数1〜6のもの、例えばメチル基、エチル基
、プロピル基、ブチル基、ペンチル基、ヘキシル基など
が挙げられ、それらは直鎖又は枝分れ脂肪鎖の構造異性
のものも含み、R1及びR2に含まれるシクロアルキル
基としては、炭素数3〜6のもの、例えばシクロプロピ
ル基、シクロブチル基、シクロペンチル基、シクロヘキ
シル基などが挙げられる。また、R1、R2、R3、X
及びYに含まれるハロゲン原子としては、弗素、塩素、
臭素又は沃素の各原子が挙げられる。
In general formula (I), R1, R2, R3, R5
, X and Y include those having 1 to 6 carbon atoms, such as methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, etc. The cycloalkyl group included in R1 and R2 includes those with structural isomerism of branched aliphatic chains, such as those having 3 to 6 carbon atoms, such as cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, etc. . Also, R1, R2, R3, X
The halogen atoms contained in Y include fluorine, chlorine,
Examples include bromine or iodine atoms.

【0006】一般式(I)で表わされるスルホニル尿素
系化合物の塩としては、ナトリウム、カリウムなどのア
ルカリ金属塩、マグネシウム、カルシウムなどのアルカ
リ土類金属塩、モノメチルアミン、ジメチルアミン、ト
リメチルアミンなどのアミン塩が挙げられる。
Examples of the salt of the sulfonylurea compound represented by the general formula (I) include salts of alkali metals such as sodium and potassium, salts of alkaline earth metals such as magnesium and calcium, and amines such as monomethylamine, dimethylamine and trimethylamine. Salt is an example.

【0007】一般式(I)で表わされるスルホニル尿素
系化合物は、例えば次の〔A〕〜〔D〕のような方法に
よって製造することができる。
The sulfonylurea compound represented by the general formula (I) can be produced, for example, by the following methods [A] to [D].

【0008】〔A〕[A]

【化5】 〔B〕[C5] [B]

【化6】 〔C〕[C6] [C]

【化7】 〔D〕[C7] [D]

【化8】[Chemical formula 8]

【0009】〔A〕〜〔D〕の反応中、R1、R2、R
3、X、Y及びAは前述の通りであり、R4はアルキル
基又はアリール(aryl)基である。
During the reactions [A] to [D], R1, R2, R
3, X, Y and A are as described above, and R4 is an alkyl group or an aryl group.

【0010】R4で表わされるアルキル基としては、R
1、R2、R3、R5、X及びYについて前記したもの
と同様なアルキル基が挙げられ、アリール基としてはフ
ェニル基、塩素原子で置換されたフェニル基、メチル基
で置換されたフェニル基、ナフチル基などが挙げられる
As the alkyl group represented by R4, R
1, R2, R3, R5, the same alkyl groups as those mentioned above for Examples include groups.

【0011】反応〔A〕は塩基の存在下で行なわれ、反
応〔B〕、〔C〕及び〔D〕も必要に応じて塩基の存在
下でおこなわれる。塩基としてはトリエチルアミンのよ
うな三級アミン、1,8−ジアザビシクロ〔5.4.0
〕−7−ウンデセンなどが使用される。
Reaction [A] is carried out in the presence of a base, and reactions [B], [C] and [D] are also carried out in the presence of a base, if necessary. As a base, tertiary amine such as triethylamine, 1,8-diazabicyclo[5.4.0
]-7-undecene etc. are used.

【0012】また反応〔A〕、〔B〕、〔C〕及び〔D
〕は通常溶媒の存在下でおこなわれる。溶媒としては、
ベンゼン、トルエン、キシレン、クロロベンゼンなどの
芳香族炭化水素類;クロロホルム、四塩化炭素、塩化メ
チレン、ジクロロエタン、トリクロロエタン、ヘキサン
、シクロヘキサンなどの環状又は非環状脂肪族炭化水素
類;ジエチルエーテル、ジオキサン、テトラヒドロフラ
ンなどのエーテル類;アセトニトリル、プロピオニトリ
ル、アクリロニトリルなどのニトリル類;アセトン、メ
チルエチルケトンなどのケトン類;酢酸メチル、酢酸エ
チルなどのエステル類;ジメチルスルホキシド、スルホ
ランなどの非プロトン性極性溶媒などが挙げられる。
[0012] Also, reactions [A], [B], [C] and [D
] is usually carried out in the presence of a solvent. As a solvent,
Aromatic hydrocarbons such as benzene, toluene, xylene, and chlorobenzene; Cyclic or acyclic aliphatic hydrocarbons such as chloroform, carbon tetrachloride, methylene chloride, dichloroethane, trichloroethane, hexane, and cyclohexane; diethyl ether, dioxane, tetrahydrofuran, etc. Nitriles such as acetonitrile, propionitrile, and acrylonitrile; Ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; and aprotic polar solvents such as dimethyl sulfoxide and sulfolane.

【0013】反応〔A〕の反応温度は通常−20〜+1
00℃、望ましくは0〜40℃であり、反応時間は0.
01〜100時間、望ましくは0.1〜24時間であり
、反応〔B〕の反応温度は通常0〜150℃であり、反
応時間は0.1〜24時間であり、反応〔C〕の反応温
度は通常0〜150℃であり、反応時間は0.1〜24
時間であり、反応〔D〕の反応温度は通常−20〜+1
50℃であり、反応時間は0.1〜24時間である。
[0013] The reaction temperature of reaction [A] is usually -20 to +1
00°C, preferably 0 to 40°C, and the reaction time is 0.00°C, preferably 0 to 40°C.
01 to 100 hours, preferably 0.1 to 24 hours, the reaction temperature of reaction [B] is usually 0 to 150 °C, the reaction time is 0.1 to 24 hours, and the reaction time of reaction [C] is usually 0 to 150 °C. The temperature is usually 0-150°C, and the reaction time is 0.1-24°C.
time, and the reaction temperature of reaction [D] is usually -20 to +1
The temperature is 50°C and the reaction time is 0.1 to 24 hours.

【0014】また、一般式(I)で表わされるスルホニ
ル尿素系化合物は、例えば次の〔E〕のような方法によ
っても製造することができる。
The sulfonylurea compound represented by the general formula (I) can also be produced, for example, by the following method [E].

【0015】〔E〕[E]

【化9】[Chemical formula 9]

【0016】(式中、R1、R2、R3、X、Y及びA
は前述の通りである)
(wherein R1, R2, R3, X, Y and A
is as described above)

【0017】反応〔E〕は通常塩基及び溶媒の存在下で
おこなわれるが、それらは前記反応〔A〕〜〔D〕にお
いて使用されるものと同様のものが挙げられる。
Reaction [E] is usually carried out in the presence of a base and a solvent, which may be the same as those used in reactions [A] to [D] above.

【0018】反応〔E〕の反応温度は通常−10〜+1
50℃、望ましくは室温〜100℃であり、反応時間は
0.1〜48時間、望ましくは0.5〜24時間である
[0018] The reaction temperature of reaction [E] is usually -10 to +1
The temperature is 50°C, preferably room temperature to 100°C, and the reaction time is 0.1 to 48 hours, preferably 0.5 to 24 hours.

【0019】反応〔A〕及び〔B〕中の(II−1)で
表わされる置換ピリジン系化合物は、新規化合物であり
、例えば次の〔F〕及び〔G〕のような方法で製造する
ことができる。
The substituted pyridine compound represented by (II-1) in reactions [A] and [B] is a new compound, and can be produced, for example, by the following methods [F] and [G]. Can be done.

【0020】〔F〕[F]

【化10】[Chemical formula 10]

【0021】反応〔F〕中、1〜17の各反応工程は次
のような反応条件である。 1.PhCH2SH、塩基、溶媒、80〜170℃2.
(i)50%aq.酢酸、Cl2、−10〜+10℃ (ii)Bu(t)−NH2、溶媒、0℃〜室温3.R
2NH2、必要に応じてCuCl及び/又は溶媒、10
0〜200℃ 4.R1COCl、溶媒、塩基、−10〜+100℃5
.CF3CO2H、室温〜還流温度 6.NH3、必要に応じてCuCl及び/又は溶媒、1
00〜200℃ 7.R2T′、塩基、溶媒、−10〜+100℃8.(
i)50%aq.酢酸、Cl2、−10〜+10℃ (ii)Bu(t)−NH2、溶媒、0℃〜室温9.R
1COCl、溶媒、塩基、−10〜+100℃10.(
i)50%aq.酢酸、Cl2、−10〜+10℃ (ii)Bu(t)−NH2、溶媒、0℃〜室温11.
(i)50%aq.酢酸、Cl2、−10〜+10℃ (ii)NH3、溶媒、0℃〜室温 12.R1COCl、溶媒、塩基、−10〜+100℃
13.R2T′、溶媒、塩基、−10〜+100℃14
.NH3、溶媒、必要に応じてCuCl、100〜20
0℃ 15.R1COCl、溶媒、塩基、−10℃〜室温16
.R2T′、溶媒、塩基、−10〜+100℃17.R
2T′、溶媒、塩基、−10〜+100℃
In reaction [F], each of reaction steps 1 to 17 has the following reaction conditions. 1. PhCH2SH, base, solvent, 80-170°C2.
(i) 50% aq. Acetic acid, Cl2, -10 to +10°C (ii) Bu(t)-NH2, solvent, 0°C to room temperature3. R
2NH2, optionally CuCl and/or solvent, 10
0-200℃ 4. R1COCl, solvent, base, -10 to +100°C5
.. CF3CO2H, room temperature to reflux temperature6. NH3, optionally CuCl and/or solvent, 1
00-200℃ 7. R2T', base, solvent, -10 to +100°C8. (
i) 50% aq. Acetic acid, Cl2, -10 to +10°C (ii) Bu(t)-NH2, solvent, 0°C to room temperature9. R
1 COCl, solvent, base, -10 to +100°C10. (
i) 50% aq. Acetic acid, Cl2, -10 to +10°C (ii) Bu(t)-NH2, solvent, 0°C to room temperature 11.
(i) 50% aq. Acetic acid, Cl2, -10 to +10°C (ii) NH3, solvent, 0°C to room temperature 12. R1COCl, solvent, base, -10 to +100°C
13. R2T', solvent, base, -10 to +100℃14
.. NH3, solvent, CuCl as necessary, 100-20
0℃ 15. R1COCl, solvent, base, -10°C to room temperature 16
.. R2T', solvent, base, -10 to +100°C17. R
2T', solvent, base, -10 to +100°C

【0022】
〔G〕
[0022]
[G]

【化11】[Chemical formula 11]

【0023】反応〔G〕中、18〜26の各反応工程は
次のような反応条件である。 18.NH3、溶媒、必要に応じてCuCl、100〜
200℃ 19.R1COCl、塩基、溶媒、−10〜+100℃
20.R2T′、塩基、溶媒、−10〜+100℃21
.NaSH、溶媒、50〜200℃又は(i)SC(N
H2)2、酢酸、必要に応じて溶媒、50℃〜還流温度 (ii)塩基、必要に応じて溶媒、0〜100℃22.
(i)50%aq.酢酸、Cl2、−10〜+10℃ (ii)NH3、溶媒、0℃〜室温 23.R2NH2、溶媒、必要に応じてCuCl、10
0〜200℃ 24.R1COCl、塩基、溶媒、−10〜+100℃
25.PhCH2SH、塩基、溶媒、80〜170℃2
6.(i)50%aq.酢酸、Cl2、−10〜+10
℃ (ii)NH3、溶媒、0℃〜室温
In reaction [G], each of reaction steps 18 to 26 has the following reaction conditions. 18. NH3, solvent, CuCl as necessary, 100~
200℃ 19. R1COCl, base, solvent, -10 to +100°C
20. R2T', base, solvent, -10 to +100℃21
.. NaSH, solvent, 50-200°C or (i) SC(N
H2) 2, acetic acid, solvent if necessary, 50°C to reflux temperature (ii) base, solvent if necessary, 0 to 100°C22.
(i) 50% aq. Acetic acid, Cl2, -10 to +10°C (ii) NH3, solvent, 0°C to room temperature 23. R2NH2, solvent, CuCl if necessary, 10
0-200℃ 24. R1COCl, base, solvent, -10 to +100°C
25. PhCH2SH, base, solvent, 80-170℃2
6. (i) 50% aq. Acetic acid, Cl2, -10 to +10
°C (ii) NH3, solvent, 0 °C to room temperature

【0024】反応〔F〕及び〔G〕中、R1、R2及び
R3は前述の通りであり、T及びT′は各々独立して塩
素、臭素等のハロゲン原子である。また、Phはフェニ
ル基を、Bu(t)はターシャリーブチル基を、aq.
は水溶液を各々示す。
In reactions [F] and [G], R1, R2 and R3 are as described above, and T and T' are each independently a halogen atom such as chlorine or bromine. In addition, Ph represents a phenyl group, Bu(t) represents a tertiary butyl group, and aq.
indicates an aqueous solution.

【0025】また反応〔C〕中の(II−2)で表わさ
れる化合物は、例えば次の〔H〕のような方法で、さら
に反応〔D〕中の(II−3)で表わされる化合物は、
例えば次の〔I〕のような方法で製造することができる
The compound represented by (II-2) in reaction [C] can be prepared, for example, by the following method [H], and the compound represented by (II-3) in reaction [D] can be prepared by the following method [H]. ,
For example, it can be manufactured by the following method [I].

【0026】 反応式〔H〕又は〔I〕中、R1、R2、R3及びR4
は前述の通りである。
In reaction formula [H] or [I], R1, R2, R3 and R4
is as described above.

【0027】前記反応式〔E〕中の(IV)で表わされ
る化合物は、前記反応〔F〕中の(VI)で表わされる
化合物を用いて、例えば次の〔J〕のような方法で製造
することができる。
The compound represented by (IV) in the above reaction formula [E] can be produced using the compound represented by (VI) in the above reaction [F], for example, by the following method [J]. can do.

【0028】〔J〕[J]

【化12】[Chemical formula 12]

【0029】(式中、R2、R3、X、Y、A及びPh
は前述の通りである)
(wherein R2, R3, X, Y, A and Ph
is as described above)

【0030】反応〔J〕第1工程の反応温度は通常室温
〜還流温度、反応時間は0.1〜24時間、望ましくは
0.5〜5時間であり、第2工程の反応温度は通常0℃
〜還流温度であり、望ましくは10℃〜室温であり、反
応時間は0.05〜24時間、望ましくは0.1〜1時
間である。
Reaction [J] The reaction temperature in the first step is usually room temperature to reflux temperature, the reaction time is 0.1 to 24 hours, preferably 0.5 to 5 hours, and the reaction temperature in the second step is usually 0.1 to 24 hours, preferably 0.5 to 5 hours. ℃
- reflux temperature, preferably 10°C - room temperature, and reaction time is 0.05-24 hours, preferably 0.1-1 hour.

【0031】また、反応〔E〕〜〔G〕中のR1COC
lで表わされる化合物は、例えば次の〔K〕のような方
法で製造することができる。 溶    媒 必要に応じて触媒、50℃〜還流温度 (式中、R1は前述の通りである)
[0031] Furthermore, R1COC in reactions [E] to [G]
The compound represented by l can be produced, for example, by the following method [K]. Solvent, catalyst if necessary, 50°C to reflux temperature (in the formula, R1 is as described above)

【0032】反応〔K〕中のR1CO2Hで表わされる
化合物は通常の方法により容易に得られるが、置換され
てもよいピコリン酸の場合は、例えば次の〔L〕のよう
な方法で製造してもよい。
The compound represented by R1CO2H in reaction [K] can be easily obtained by a conventional method, but in the case of optionally substituted picolinic acid, it can be produced, for example, by the following method [L]. Good too.

【0033】〔L〕[L]

【化13】[Chemical formula 13]

【0034】{式中、Tは前述の通りであり、R6はハ
ロゲン原子、アルキル基、ハロアルキル基、アルコキシ
基、−NO2基であり、nは0〜4の整数(nが2〜4
の整数のときR6は同一又は異なってもよい)である}
{In the formula, T is as described above, R6 is a halogen atom, alkyl group, haloalkyl group, alkoxy group, -NO2 group, and n is an integer of 0 to 4 (n is 2 to 4
R6 may be the same or different when R6 is an integer)

【0035】〔F〕〜〔L〕の各反応の反応温度、反応
時間、溶媒(必要に応じて使用される溶媒)、塩基物質
、必要に応じて使用される触媒などの反応条件は、特に
記載のない場合には通常類似の反応における反応条件か
ら適宜選択できる。
[0035] The reaction conditions for each reaction [F] to [L], such as reaction temperature, reaction time, solvent (solvent used as necessary), basic substance, and catalyst used as necessary, are particularly Unless otherwise specified, the reaction conditions can be selected appropriately from the reaction conditions of similar reactions.

【0036】また、一般式(I)で表わされる前記スル
ホニル尿素系化合物の塩は、通常の製造方法によって容
易に得られる。
Further, the salt of the sulfonylurea compound represented by the general formula (I) can be easily obtained by a conventional manufacturing method.

【0037】一般式(I)で表わされるスルホニル尿素
系化合物は、後記試験例にみる通り、低薬量で広い殺草
スペクトラムを示し、同時に小麦、ダイズ又はテンサイ
に対して安全性を示すものを含む。従って、一般式(I
)で表わされる化合物又はその塩は除草剤の有効成分と
して有用である。
As shown in the test examples below, the sulfonylurea compound represented by the general formula (I) exhibits a wide herbicidal spectrum at low doses, and at the same time shows safety against wheat, soybean, or sugar beet. include. Therefore, the general formula (I
) or a salt thereof is useful as an active ingredient of herbicides.

【0038】一般式(I)で表わされる化合物又はその
塩を有効成分として含有する本発明除草剤を施用する場
合、通常は担体、必要に応じて希釈剤、溶剤、乳化剤、
展着剤、界面活性剤などの各種補助剤と混合して、粒剤
、顆粒水和剤、水和剤、乳剤、液剤、懸濁剤などに製剤
して使用する。有効成分化合物と農薬用補助剤との適当
な配合重量比は、一般に1:99〜90:10、望まし
くは5:95〜80:20である。有効成分化合物の使
用適量は気象条件、土壌条件、薬剤の製剤形態、対象雑
草の種類、施用時期などの相違により一概に規定できな
いが、一般に1アール当りの施用有効成分量としては0
.005g〜50g、望ましくは0.01g〜10g、
更に望ましくは0.05g〜5gである。
When applying the herbicide of the present invention containing the compound represented by formula (I) or a salt thereof as an active ingredient, a carrier, if necessary a diluent, a solvent, an emulsifier,
It is used by mixing with various auxiliary agents such as spreading agents and surfactants to formulate granules, wettable powders, wettable powders, emulsions, solutions, suspensions, etc. A suitable weight ratio of the active ingredient compound to the pesticide adjuvant is generally 1:99 to 90:10, preferably 5:95 to 80:20. The appropriate amount of the active ingredient compound to be used cannot be determined unconditionally due to differences in weather conditions, soil conditions, drug formulation, target weed type, application period, etc., but in general, the amount of the active ingredient applied per are is 0.
.. 005g to 50g, preferably 0.01g to 10g,
More preferably, it is 0.05g to 5g.

【0039】以下に本発明除草剤の製剤例を記載する。 以上の各成分を高速混合細粒機に入れ、さらにそこへ2
0%の水を加え造粒・乾燥して顆粒の水和剤が得られる
Examples of formulations of the herbicide of the present invention are described below. Put each of the above ingredients into a high-speed mixing granulator, and then add 2
Add 0% water, granulate and dry to obtain a granular wettable powder.

【0040】製剤例2 (商品名:塩野義製薬(株)製)以上の(1)〜(4)
の成分の混合物と化合物NO.48とを9:1の重量割
合で混合して水和剤が得られる。
Formulation Example 2 (Product name: Shionogi & Co., Ltd.) (1) to (4) above
A mixture of components and compound NO. 48 in a weight ratio of 9:1 to obtain a wettable powder.

【0041】製剤例3 以上の各成分を混合して水和剤が得られる。Formulation example 3 A hydrating agent can be obtained by mixing the above components.

【0042】製剤例4 以上の各成分を混合して水和剤が得られる。Formulation example 4 A hydrating agent can be obtained by mixing the above components.

【0043】製剤例5 以上の(1)〜(4)の成分を均一に混合し、ダイノー
ミル(ウイリー・エ・バーホーヘン(株)製)で粉砕し
て懸濁状組成物が得られる。
Formulation Example 5 The above components (1) to (4) are mixed uniformly and pulverized with a Dyno Mill (manufactured by Willy & Verhohen) to obtain a suspension composition.

【0044】製剤例6 以上の各成分を均一に混合し、湿式粉砕して水性懸濁剤
が得られる。
Formulation Example 6 The above components are uniformly mixed and wet-pulverized to obtain an aqueous suspension.

【0045】本発明除草剤は他の農薬、農薬補助剤、薬
害軽減剤などと混用或は併用することができ、この場合
に一層優れた効果・作用性を示すことがある。他の除草
剤と混用或は併用する場合、その混用相手除草剤の有効
成分としては、例えば次のようなものが挙げられる。・
(±)−2−〔4−〔(6−クロロ−2−キノキサリニ
ル)オキシ〕フェノキシ〕プロピオン酸エチル(一般名
;キザロホップエチル)・3−(1−メチルエチル)−
(1H)−2,1,3−ベンゾチアジアジン−4−(3
H)−オン−2,2−ジオキシド(一般名;ベンタゾン
)・5−〔2−クロロ−4−(トリフルオロメチル)フ
ェノキシ〕−2−ニトロ安息香酸ナトリウム(一般名;
アシフルオルフェン)・2−〔〔〔〔(4−クロロ−6
−メトキシ−2−ピリミジニル)アミノ〕カルボニル〕
アミノ〕スルホニル〕安息香酸エチル(一般名;クロリ
ムロンエチル:Chloimuron−ethyl)・
(±)−5−〔2−クロロ−4−(トリフルオロメチル
)フェノキシ〕−2−ニトロ安息香酸2−エトキシ−1
−メチル−2−オキソエチル(一般名;ラクトフェン)
・4−(2,4−ジクロロフェノキシ)酪酸(一般名;
2,4−ディービー:2,4−DB)・2−クロロ−N
−(2−エチル−6−メチルフェニル)−N−(2−メ
トキシ−1−メチルエチル)アセトアミド(一般名;メ
トラクロール)・(±)−2−〔4−〔(6−クロロ−
2−ベンゾキサゾリル)オキシ〕フェノキシ〕プロピオ
ン酸エチル(一般名;フェノキサプロップエチル)・(
±)−2−〔4−〔〔5−(トリフルオロメチル)−2
−ピリジニル〕オキシ〕フェノキシ〕プロピオン酸ブチ
ル(一般名;フルアジホップ)・2−クロロ−N−(2
,6−ジエチルフェニル)−N−(メトキシメチル)ア
セトアミド(一般名;アラクロール)・3−(3,4−
ジクロロフェニル)−1−メトキシ−1−メチル尿素(
一般名;リニュロン)・4−アミノ−6−(1,1−ジ
メチルエチル)−3−(メチルチオ)−1,2,4−ト
リアジン−5−(4H)−オン(一般名;メトリブジン
)・2−〔1−(エトキシイミノ)ブチル〕−5−〔2
−(エチルチオ)プロピル〕−3−ヒドロキシ−2−シ
クロヘキセン−1−オン(一般名;セトキシジム)・(
±)−2−〔4,5−ジヒドロ−4−メチル−4−(1
−メチルエチル)−5−オキソ−1H−イミダゾール−
2−イル〕−5−エチル−3−ピリジンカルボン酸(一
般名;イマゼタピル)・5−〔2−クロロ−4−(トリ
フルオロメチル)フェノキシ〕−N−(メチルスルホニ
ル)−2−ニトロベンズアミド(一般名;ホメサフェン
)・2−〔4,5−ジヒドロ−4−メチル−4−(1−
メチルエチル)−5−オキソ−1H−イミダゾール−2
−イル〕−3−キノリンカルボン酸(一般名;イマザキ
ン)・2,6−ジニトロ−N,N−ジプロピル−4−(
トリフルオロメチル)アニリン(一般名;トリフルラリ
ン)・3−〔(メトキシカルボニル)アミノ〕フェニル
  (3−メチルフェニル)カーバメート(一般名;フ
ェンメディファム)・エチル  〔3−〔〔(フェニル
アミノ)カルボニル〕オキシ〕フェニル〕カーバメート
(一般名;デスメディファム)・7−オキサビシクロ〔
2.2.1〕ヘプタン−2,3−ジカルボン酸(一般名
;エンドタール)・エチル  ジイソプロピルチオカー
バメート(一般名;イーピーティーシー:EPTC)・
2−〔4−〔(3−クロロ−5−(トリフルオロメチル
)−2−ピリジニル〕オキシ〕フェノキシ〕プロピオン
酸メチル(一般名;ハロキシホップ)・(±)−メタン
スルホン酸2−エトキシ−2,3−ジヒドロ−3,3−
ジメチル−5−ベンゾフラニル(一般名;エトフメセー
ト)・5−アミノ−4−クロロ−2−フェニル−3−(
2H)−ピリダジノン(一般名;クロリダゾン)・2−
〔〔〔〔(4−メトキシ−6−メチル−1,3,5−ト
リアジン−2−イル)アミノ〕カルボニル〕アミノ〕ス
ルホニル〕安息香酸メチル(一般名;メツルフロン−メ
チル)・6−(4−イソプロピル−4−メチル−5−オ
キソ−2−イミダゾリン−2−イル)−m−トルイル酸
メチル及び2−(4−イソプロピル−4−メチル−5−
オキソ−2−イミダゾリン−2−イル)−P−トルイル
酸メチル(一般名;イマザメタベンズ)・1,2−ジメ
チル−3,5−ジフェニル−1H−ピラゾリン  メチ
ル硫酸塩(一般名;ジフェンゾコート)・3,6−ジク
ロロ−2−メトキシ安息香酸(一般名;ジカンバ)・3
,5−ジブロモ−4−ヒドロキシベンゾニトリル(一般
名;ブロモキシニル)・4−ヒドロキシ−3,5−ジヨ
ードベンゾニトリル(一般名;アイオキシニル)・2,
4−ジクロロフェノキシ酢酸(一般名;2,4−ディ−
:2,4−D)N′−(3,4−ジクロロフェニル)−
N,N−ジメチル尿素(一般名;ジウロン)・2−〔〔
〔〔N−(4−メトキシ−6−メチル−1,3,5−ト
リアジン−2−イル)メチルアミノ〕カルボニル〕アミ
ノ〕スルホニル〕安息香酸メチル(一般名;トリベンウ
ロン:tribenuron)・s−(2,3,3−ト
リクロロ−2−プロペニル)−ビス−(1−メチルエチ
ル)  チオカーバメート(一般名;トリアレート)・
2−クロロ−N−〔〔(4−メトキシ−6−メチル−1
,3,5−トリアジン−2−イル〕アミノ〕カルボニル
〕ベンゼンスルホンアミド(一般名;クロルスルフロン
)・3−〔〔〔〔(4−メトキシ−6−メチル−1,3
,5−トリアジン−2−イル)アミノ〕カルボニル〕ア
ミノ〕スルホニル〕−2−チオフェンカルボン酸メチル
(一般名;チアメツロン−メチル:thiametur
on−methyl)・(±)−2−〔4−(2,4−
ジクロロフェノキシ)フェノキシ〕プロピオン酸メチル
(一般名;ジクロホップ−メチル)・4−クロロ−2−
メチルフェノキシ酢酸(一般名;エムシーピーエー:M
CPA)・4−アミノ−6−(1,1−ジメチルエチル
)−3−(メチルチオ)−1,2,4−トリアジン−5
−(4H)−オン(一般名;メトリブジン)・3,6−
ジクロロ−2−ピリジンカルボン酸(一般名;クロピラ
リド)・4−アミノ−3,5,6−トリクロロ−2−ピ
リジンカルボン酸(一般名;ピクロラム)・O−(6−
クロロ−3−フェニル−4−ピリダジニル)−S−オク
チル  チオカーバメート
The herbicide of the present invention can be mixed or used in combination with other agricultural chemicals, agricultural chemical auxiliaries, phytotoxicity reducers, etc., and in this case may exhibit even better effects and action. When mixed or used in combination with other herbicides, examples of the active ingredients of the herbicides to be mixed include the following.・
(±)-2-[4-[(6-chloro-2-quinoxalinyl)oxy]phenoxy]ethylpropionate (common name: quizalofopethyl)・3-(1-methylethyl)-
(1H)-2,1,3-benzothiadiazine-4-(3
H)-one-2,2-dioxide (common name; bentazone)/sodium 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate (common name;
acifluorfen)・2-[[[[(4-chloro-6
-methoxy-2-pyrimidinyl)amino]carbonyl]
Amino]sulfonyl]ethyl benzoate (common name; Chloimuron-ethyl)
(±)-5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid 2-ethoxy-1
-Methyl-2-oxoethyl (common name: lactofen)
・4-(2,4-dichlorophenoxy)butyric acid (common name;
2,4-DB:2,4-DB)・2-chloro-N
-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl)acetamide (common name: metolachlor) (±)-2-[4-[(6-chloro-
Ethyl 2-benzoxazolyloxy[phenoxy]propionate (common name: fenoxaprop ethyl) (
±)-2-[4-[[5-(trifluoromethyl)-2
-pyridinyl]oxy]phenoxy]butyl propionate (common name: fluazifop)・2-chloro-N-(2
,6-diethylphenyl)-N-(methoxymethyl)acetamide (common name: alachlor)・3-(3,4-
dichlorophenyl)-1-methoxy-1-methylurea (
Generic name: linuron)・4-amino-6-(1,1-dimethylethyl)-3-(methylthio)-1,2,4-triazin-5-(4H)-one (generic name: metribuzin)・2 -[1-(ethoxyimino)butyl]-5-[2
-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one (common name: setoxydim) (
±)-2-[4,5-dihydro-4-methyl-4-(1
-methylethyl)-5-oxo-1H-imidazole-
2-yl]-5-ethyl-3-pyridinecarboxylic acid (generic name: imazethapyr) 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulfonyl)-2-nitrobenzamide ( Generic name: Fomesafen)・2-[4,5-dihydro-4-methyl-4-(1-
methylethyl)-5-oxo-1H-imidazole-2
-yl]-3-quinolinecarboxylic acid (generic name: imazaquin)・2,6-dinitro-N,N-dipropyl-4-(
trifluoromethyl)aniline (common name; trifluralin), 3-[(methoxycarbonyl)amino]phenyl (3-methylphenyl)carbamate (common name; phenmedipham), ethyl [3-[[(phenylamino)carbonyl] Oxy]phenyl]carbamate (generic name: desmedipham), 7-oxabicyclo[
2.2.1] Heptane-2,3-dicarboxylic acid (generic name; Endothal)・Ethyl diisopropylthiocarbamate (generic name; EPTC)・
Methyl 2-[4-[(3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propionate (common name: haloxyfop), (±)-2-ethoxy-2-methanesulfonic acid, 3-dihydro-3,3-
Dimethyl-5-benzofuranyl (common name: ethofumesate), 5-amino-4-chloro-2-phenyl-3-(
2H)-pyridazinone (generic name: chloridazone)・2-
[[[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]amino]sulfonyl]methyl benzoate (common name; metsulfuron-methyl) 6-(4- Methyl isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-m-toluate and 2-(4-isopropyl-4-methyl-5-
Methyl oxo-2-imidazolin-2-yl)-P-toluate (generic name: imazametabenz)・1,2-dimethyl-3,5-diphenyl-1H-pyrazoline methyl sulfate (generic name: dipenzocort)・3, 6-dichloro-2-methoxybenzoic acid (common name: dicamba) 3
, 5-dibromo-4-hydroxybenzonitrile (common name: bromoxynil), 4-hydroxy-3,5-diiodobenzonitrile (common name: ioxynil), 2,
4-dichlorophenoxyacetic acid (common name: 2,4-di-
:2,4-D)N'-(3,4-dichlorophenyl)-
N,N-dimethylurea (common name: diuron)・2-[[
[[N-(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)methylamino]carbonyl]amino]sulfonyl]methylbenzoate (common name; tribenuron) s-(2 ,3,3-trichloro-2-propenyl)-bis-(1-methylethyl) thiocarbamate (common name: trialate).
2-chloro-N-[[(4-methoxy-6-methyl-1
,3,5-triazin-2-yl]amino]carbonyl]benzenesulfonamide (common name: chlorsulfuron)・3-[[[[(4-methoxy-6-methyl-1,3
,5-triazin-2-yl)amino]carbonyl]amino]sulfonyl]-2-thiophenecarboxylic acid methyl (common name; thiameturon-methyl: thiametur
on-methyl)・(±)-2-[4-(2,4-
Dichlorophenoxy) phenoxy]methyl propionate (common name: diclofop-methyl), 4-chloro-2-
Methylphenoxyacetic acid (generic name; MCP: M
CPA)・4-amino-6-(1,1-dimethylethyl)-3-(methylthio)-1,2,4-triazine-5
-(4H)-one (generic name: metribuzin)・3,6-
Dichloro-2-pyridinecarboxylic acid (common name: clopyralid), 4-amino-3,5,6-trichloro-2-pyridinecarboxylic acid (common name: picloram), O-(6-
Chloro-3-phenyl-4-pyridazinyl)-S-octyl thiocarbamate

【0046】本発明除草剤の適用範囲は、畑地、果樹園
、桑園などの農耕地、山林、農道、グラウンド、工場敷
地などの非農耕地と多岐にわたり、又適用方法も土壌処
理、茎葉処理を適宜選択できる。
The scope of application of the herbicide of the present invention is wide-ranging, including agricultural land such as fields, orchards, and mulberry orchards, as well as non-agricultural land such as mountains and forests, farm roads, grounds, and factory sites. Application methods include soil treatment, foliage treatment, etc. You can choose as appropriate.

【0047】[0047]

【実施例】以下に本発明化合物の具体的合成例並びに生
物試験例を記載するが、本発明はこれらに限定されるも
のではない。
EXAMPLES Specific synthesis examples and biological test examples of the compounds of the present invention are described below, but the present invention is not limited thereto.

【0048】合成例1    4−トリフルオロメチル
−N−〔6−〔〔(4,6−ジメトキシピリミジン−2
−イル)アミノカルボニル〕アミノスルホニル〕ピリジ
ン−2−イル〕−N−メチルベンズアミド(後記化合物
No.48)の合成
Synthesis Example 1 4-Trifluoromethyl-N-[6-[[(4,6-dimethoxypyrimidine-2
Synthesis of -yl)aminocarbonyl]aminosulfonyl]pyridin-2-yl]-N-methylbenzamide (compound No. 48 below)

【0049】1)  2,6−ジクロロピリジン250
g、ジメチルスルホキシド500ml及び無水炭酸カリ
ウム256.8gの混合液を110℃まで加熱した。こ
の中へ約1時間でベンジルメルカプタン230.4gを
滴下した。滴下終了後110℃でさらに約1時間反応さ
せた。反応終了後、反応混合物を1000mlの水中に
投入し、塩化メチレンで抽出した。塩化メチレン層を1
0%水酸化ナトリウム水溶液で洗浄した後、水洗し、無
水硫酸ナトリウムで乾燥した。その後減圧下塩化メチレ
ンを留去することによりオイル状の2−ベンジルチオ−
6−クロロピリジン430g得た。
1) 2,6-dichloropyridine 250
A mixture of 500 ml of dimethyl sulfoxide and 256.8 g of anhydrous potassium carbonate was heated to 110°C. 230.4 g of benzyl mercaptan was dropped into this over about 1 hour. After the dropwise addition was completed, the reaction was continued at 110° C. for about 1 hour. After the reaction was completed, the reaction mixture was poured into 1000 ml of water and extracted with methylene chloride. 1 layer of methylene chloride
After washing with 0% aqueous sodium hydroxide solution, it was washed with water and dried over anhydrous sodium sulfate. Thereafter, by distilling off methylene chloride under reduced pressure, an oily 2-benzylthio-
430 g of 6-chloropyridine was obtained.

【0050】2)  2−ベンジルチオ−6−クロロピ
リジン430g、酢酸500ml及び水900mlの混
合液を氷冷し、0℃〜5℃で塩素ガスを導入した。過剰
の塩素ガスが認められるまで導入し、反応させた。反応
終了後、反応系内に窒素ガスをバブルし過剰の塩素ガス
を追い出した。反応物を氷水中に投入し、塩化メチレン
抽出を行ない、塩化メチレン層を氷水洗浄した後、無水
硫酸ナトリウムで乾燥した。次いで塩化メチレン溶液を
氷冷し、ターシャリーブチルアミン401gを約2時間
で滴下し反応させた。反応終了後、水中へ投入し、分液
した。塩化メチレン層を無水硫酸ナトリウムで乾燥し、
塩化メチレンを留去した。残査にエーテルとn−ヘキサ
ン混合物を加え結晶化させ、生じた結晶を濾取、減圧乾
燥して6−クロロ−N−ターシャリーブチル−2−ピリ
ジンスルホンアミド280gを得た。
2) A mixed solution of 430 g of 2-benzylthio-6-chloropyridine, 500 ml of acetic acid and 900 ml of water was cooled with ice, and chlorine gas was introduced at 0°C to 5°C. The mixture was introduced and reacted until excess chlorine gas was detected. After the reaction was completed, nitrogen gas was bubbled into the reaction system to drive out excess chlorine gas. The reaction product was poured into ice water, extracted with methylene chloride, and the methylene chloride layer was washed with ice water and then dried over anhydrous sodium sulfate. Next, the methylene chloride solution was ice-cooled, and 401 g of tert-butylamine was added dropwise over about 2 hours to cause a reaction. After the reaction was completed, it was poured into water and the liquid was separated. Dry the methylene chloride layer with anhydrous sodium sulfate,
Methylene chloride was distilled off. A mixture of ether and n-hexane was added to the residue for crystallization, and the resulting crystals were collected by filtration and dried under reduced pressure to obtain 280 g of 6-chloro-N-tert-butyl-2-pyridinesulfonamide.

【0051】3)  6−クロロ−N−ターシャリーブ
チル−2−ピリジンスルホンアミド25g、20%メチ
ルアミン水溶液150ml及び塩化第一銅0.5gを2
00mlミニオートクレーブに仕込み、150℃で約3
時間反応させた。反応終了後、放冷し、内容物を水中に
投入した。生じた結晶を濾取し、水洗し、乾燥して融点
157〜160℃の目的物22.7gを得た。
3) 25 g of 6-chloro-N-tert-butyl-2-pyridine sulfonamide, 150 ml of 20% methylamine aqueous solution and 0.5 g of cuprous chloride
Pour into a 00ml mini autoclave and heat at 150℃ for approx.
Allowed time to react. After the reaction was completed, the mixture was allowed to cool and the contents were poured into water. The resulting crystals were collected by filtration, washed with water, and dried to obtain 22.7 g of the desired product having a melting point of 157 to 160°C.

【0052】4)  N−ターシャリーブチル−6−メ
チルアミノ−2−ピリジンスルホンアミド1.0g及び
トリエチルアミン0.42gを1,2−ジクロロエタン
20mlに溶解させ、室温下で撹拌しているところへ4
−トリフルオロメチルベンゾイルクロライド0.86g
を加え、その後還流温度で20時間撹拌下に反応させた
。 反応終了後、溶媒を減圧留去し、シリカゲルカラムクロ
マトグラフィーで精製して融点168〜170℃のN−
〔6−(ターシャリーブチルアミノスルホニル)ピリジ
ン−2−イル〕−4−トリフルオロメチル−N−メチル
ベンズアミド1.3gを得た。
4) Dissolve 1.0 g of N-tert-butyl-6-methylamino-2-pyridinesulfonamide and 0.42 g of triethylamine in 20 ml of 1,2-dichloroethane, and add to the solution while stirring at room temperature.
-Trifluoromethylbenzoyl chloride 0.86g
was added thereto, and the reaction was then carried out under stirring at reflux temperature for 20 hours. After the reaction, the solvent was distilled off under reduced pressure and purified by silica gel column chromatography to obtain N-
1.3 g of [6-(tert-butylaminosulfonyl)pyridin-2-yl]-4-trifluoromethyl-N-methylbenzamide was obtained.

【0053】5)  N−〔6−(ターシャリーブチル
アミノスルホニル)ピリジン−2−イル〕−4−トリフ
ルオロメチル−N−メチルベンズアミド2.0gにトリ
フルオロ酢酸20mlを加え、室温で20時間撹拌下に
反応させた。反応終了後、溶媒を減圧留去し、シリカゲ
ルカラムクロマトグラフィーで精製して融点160〜1
62℃のN−〔6−(アミノスルホニル)ピリジン−2
−イル〕−4−トリフルオロ−N−メチルベンズアミド
1.33gを得た。
5) Add 20 ml of trifluoroacetic acid to 2.0 g of N-[6-(tert-butylaminosulfonyl)pyridin-2-yl]-4-trifluoromethyl-N-methylbenzamide, and stir at room temperature for 20 hours. I reacted below. After the reaction, the solvent was distilled off under reduced pressure and purified by silica gel column chromatography to obtain a melting point of 160-1.
N-[6-(aminosulfonyl)pyridine-2 at 62°C
1.33 g of -yl]-4-trifluoro-N-methylbenzamide was obtained.

【0054】6)  N−〔6−(アミノスルホニル)
ピリジン−2−イル〕−4−トリフルオロ−N−メチル
ベンズアミド1.0g及びフェニル  (2,4−ジメ
トキシピリミジン−2−イル)カーバメート0.76g
をアセトニトリル20mlに溶解させ、室温下で撹拌し
ているところへ1,8−ジアザヒシクロ〔5.4.0〕
−7−ウンデセン0.42gを加え、その後室温で20
時間撹拌下に反応させた。反応終了後、反応液に水を加
え、塩酸にて酸性として、酢酸エチル200mlにて抽
出した。その後芒硝にて乾燥し、溶媒を減圧留去した。 得られた残査をエーテル−ヘキサン溶液を用いて結晶化
させ、析出した結品を濾取、減圧乾燥して融点139〜
141℃の目的物1.0gを得た。
6) N-[6-(aminosulfonyl)
pyridin-2-yl]-4-trifluoro-N-methylbenzamide 1.0 g and phenyl (2,4-dimethoxypyrimidin-2-yl)carbamate 0.76 g
was dissolved in 20 ml of acetonitrile, and while stirring at room temperature, 1,8-diazahicyclo[5.4.0]
Add 0.42 g of -7-undecene, then 20 g at room temperature.
The reaction was allowed to take place under stirring for an hour. After the reaction was completed, water was added to the reaction solution, acidified with hydrochloric acid, and extracted with 200 ml of ethyl acetate. Thereafter, it was dried over Glauber's salt, and the solvent was distilled off under reduced pressure. The obtained residue was crystallized using an ether-hexane solution, and the precipitated crystals were collected by filtration and dried under reduced pressure to give a melting point of 139~139.
1.0 g of the target product was obtained at 141°C.

【0055】合成例2    6−ブロモ−N−〔6−
〔〔(4,6−ジメトキシピリミジン−2−イル)アミ
ノカルボニル〕アミノスルホニル〕ピリジン−2−イル
〕−N−メチルピコリン酸アミド(後記化合物No.5
8)の合成
Synthesis Example 2 6-Bromo-N-[6-
[[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]aminosulfonyl]pyridin-2-yl]-N-methylpicolinic acid amide (compound No. 5 below)
8) Synthesis

【0056】1)  2,6−ジブロモピリジン11g
、N,N−ジメチルホルムアミド60ml及びシアン化
銅4.37gの混合物を還流下約2時間反応させた。反
応終了後、放冷し、28%アンモニア水200ml中に
投入し、塩化メチレンで抽出した。塩化メチレン層を無
水硫酸ナトリウムで乾燥した後、塩化メチレンを留去し
、残査をシリカゲルカラムクロマトグラフィーで精製し
て融点101〜104℃の2−ブロモ−6−シアノピリ
ジン1.6gを得た。
1) 11 g of 2,6-dibromopyridine
A mixture of 60 ml of N,N-dimethylformamide and 4.37 g of copper cyanide was reacted under reflux for about 2 hours. After the reaction was completed, the mixture was allowed to cool, poured into 200 ml of 28% aqueous ammonia, and extracted with methylene chloride. After drying the methylene chloride layer over anhydrous sodium sulfate, the methylene chloride was distilled off, and the residue was purified by silica gel column chromatography to obtain 1.6 g of 2-bromo-6-cyanopyridine with a melting point of 101-104°C. .

【0057】2)  2−ブロモ−6−シアノピリジン
1.4g、水酸化ナトリウム0.46g及び水15ml
の混合物を還流下約1時間反応させた。反応終了後、放
冷し、水中に投入した。塩化メチレン50mlで洗浄し
た後、水層を濃塩酸でpH2にすると結晶が析出した。 生じた結晶を濾取し、減圧乾燥して6−ブロモピコリン
酸1.17gを得た。
2) 1.4 g of 2-bromo-6-cyanopyridine, 0.46 g of sodium hydroxide and 15 ml of water
The mixture was reacted under reflux for about 1 hour. After the reaction was completed, it was allowed to cool and was poured into water. After washing with 50 ml of methylene chloride, the aqueous layer was adjusted to pH 2 with concentrated hydrochloric acid to precipitate crystals. The resulting crystals were collected by filtration and dried under reduced pressure to obtain 1.17 g of 6-bromopicolinic acid.

【0058】3)  6−ブロモピコリン酸1.16g
及びオキシ塩化リン15mlの混合液を還流下約3時間
反応させた。反応終了後、過剰のオキシ塩化リンを減圧
留去し、残査に1,2−ジクロロエタン25mlを加え
、さらにN−ターシャリーブチル−6−メチルアミノピ
リジン−2−イルスルホンアミド1.3gを加えた。こ
の中に室温でトリエチルアミン0.81gを約15分に
わたって滴下した。滴下終了後室温で約1時間反応させ
た。反応終了後、反応液を水中に投入し、塩化メチレン
抽出を行った。塩化メチレン層を無水硫酸ナトリウムで
乾燥した後、塩化メチレンを留去した。残査をシリカゲ
ルカラムクロマトグラフィーで精製して融点174〜1
76℃の6−ブロモ−N−(6−ターシャリーブチルア
ミノスルホニルピリジン−2−イル)−N−メチルピコ
リンアミド2.01gを得た。
3) 6-bromopicolinic acid 1.16g
A mixed solution of 15 ml of phosphorus oxychloride was reacted under reflux for about 3 hours. After the reaction was completed, excess phosphorus oxychloride was distilled off under reduced pressure, and 25 ml of 1,2-dichloroethane was added to the residue, followed by 1.3 g of N-tert-butyl-6-methylaminopyridin-2-ylsulfonamide. Ta. 0.81 g of triethylamine was added dropwise into this at room temperature over about 15 minutes. After the dropwise addition was completed, the reaction was allowed to proceed at room temperature for about 1 hour. After the reaction was completed, the reaction solution was poured into water and extracted with methylene chloride. After drying the methylene chloride layer over anhydrous sodium sulfate, the methylene chloride was distilled off. The residue was purified by silica gel column chromatography to give a melting point of 174-1.
2.01 g of 6-bromo-N-(6-tert-butylaminosulfonylpyridin-2-yl)-N-methylpicolinamide at 76°C was obtained.

【0059】4)  6−ブロモ−N−(6−ターシャ
リーブチルアミノスルホニルピリジン−2−イル)−N
−メチルピコリン酸アミド1.6g及びトリフルオロ酢
酸20mlの混合物を室温で3時間、続いて40℃で1
時間反応させた。反応終了後、過剰のトリフルオロ酢酸
を留去し、残査にエーテルを加えて結晶化させた。生じ
た結晶を濾取し、減圧乾燥して融点178〜182℃の
N−(6−アミノスルホニルピリジン−2−イル)−6
−ブロモ−N−メチルピコリン酸アミド1.24gを得
た。
4) 6-bromo-N-(6-tert-butylaminosulfonylpyridin-2-yl)-N
- a mixture of 1.6 g methylpicolinic acid amide and 20 ml trifluoroacetic acid at room temperature for 3 hours, then at 40°C for 1 hour.
Allowed time to react. After the reaction was completed, excess trifluoroacetic acid was distilled off, and ether was added to the residue for crystallization. The resulting crystals were collected by filtration and dried under reduced pressure to give N-(6-aminosulfonylpyridin-2-yl)-6 with a melting point of 178-182°C.
1.24 g of -bromo-N-methylpicolinic acid amide was obtained.

【0060】5)  N−(6−アミノスルホニルピリ
ジン−2−イル)−6−ブロモ−N−メチルピコリン酸
アミド0.25g、フェニル(2,4−ジメトキシピリ
ミジン−2−イル)カーバメイト0.19g及びアセト
ニトリル5mlの混合物に室温で1,8−ジアザビシク
ロ〔5.4.0〕−7−ウンデセン0.1gを加えたの
ち室温で10分間反応させた。反応終了後、反応混合物
を水中に投入し塩酸にて弱酸性にして析出した固体を濾
取し、水洗し、乾燥して融点180〜185℃の目的物
0.34gを得た。
5) 0.25 g of N-(6-aminosulfonylpyridin-2-yl)-6-bromo-N-methylpicolinic acid amide, 0.19 g of phenyl(2,4-dimethoxypyrimidin-2-yl)carbamate After adding 0.1 g of 1,8-diazabicyclo[5.4.0]-7-undecene to a mixture of 1,8-diazabicyclo[5.4.0]-7-undecene and 5 ml of acetonitrile at room temperature, the mixture was reacted at room temperature for 10 minutes. After the reaction was completed, the reaction mixture was poured into water, made weakly acidic with hydrochloric acid, and the precipitated solid was collected by filtration, washed with water, and dried to obtain 0.34 g of the desired product having a melting point of 180 to 185°C.

【0061】前記合成例に準じて製造される一般式(I
I−1)で表わされる化合物の代表例を第1表に挙げる
[0061] General formula (I) produced according to the above synthesis example
Representative examples of compounds represented by I-1) are listed in Table 1.

【0062】[0062]

【表1】[Table 1]

【0063】[0063]

【表2】[Table 2]

【0064】[0064]

【表3】[Table 3]

【0065】[0065]

【表4】[Table 4]

【0066】[0066]

【表5】[Table 5]

【0067】[0067]

【表6】[Table 6]

【0068】次に前記合成例に準じて製造される一般式
(I)で表わされる化合物の代表例を第2表に挙げる。
Next, Table 2 lists representative examples of compounds represented by the general formula (I) produced according to the above synthesis example.

【0069】[0069]

【表7】[Table 7]

【0070】[0070]

【表8】[Table 8]

【0071】[0071]

【表9】[Table 9]

【0072】[0072]

【表10】[Table 10]

【0073】[0073]

【表11】[Table 11]

【0074】[0074]

【表12】[Table 12]

【0075】[0075]

【表13】[Table 13]

【0076】[0076]

【表14】[Table 14]

【0077】[0077]

【表15】[Table 15]

【0078】試験例11/1,500アールポットに畑
作土壌をつめ、各種植物の種子を播種した。その後、植
物が一定の葉令(イネ1.3〜3.7葉期、ダイズ初生
葉〜1.5葉期、トウモロコシ2.0〜4.3葉期、ワ
タ子葉〜1.2葉期、コムギ2.0〜2.8葉期、オナ
モミ1.7〜3.5葉期、アサガオ0.2〜2.5葉期
、アメリカキンゴジカ0.1〜2.5葉期、アオビユ0
.1〜2.5葉期、ヒエ1.5〜4.0葉期、メヒシバ
1.2〜2.0葉期)に達したとき、本発明除草剤の水
和剤を所定量となるように秤量し、アール当り5リット
ルの水に希釈した。更にその水溶液に農業展着剤を0.
2%となるように加えて、小型スプレーで茎葉処理した
。処理後18〜35日目に各種植物の生育状態を肉眼で
観察調査をおこない、10段階(1:無処理区と同様〜
10:完全に抑制)で生育抑制程度を評価し、第3表の
結果を得た。
Test Example 11/1,500 are pots were filled with field soil and seeds of various plants were sown. After that, the plants grow at a certain leaf age (rice 1.3-3.7 leaf stage, soybean primary leaf stage - 1.5 leaf stage, maize 2.0-4.3 leaf stage, cotton cotyledon stage - 1.2 leaf stage, Wheat 2.0-2.8 leaf stage, Japanese fir 1.7-3.5 leaf stage, morning glory 0.2-2.5 leaf stage, golden deer 0.1-2.5 leaf stage, blueberry 0
.. 1 to 2.5 leaf stage, barnyard grass 1.5 to 4.0 leaf stage, crabgrass 1.2 to 2.0 leaf stage), apply a predetermined amount of the hydrating agent of the herbicide of the present invention. Weighed and diluted in 5 liters of water per are. Furthermore, 0.0% of an agricultural spreading agent was added to the aqueous solution.
2% and treated the leaves with a small spray. 18 to 35 days after treatment, the growth status of various plants was visually observed and surveyed, and the results were graded into 10 grades (1: same as untreated area).
The degree of growth inhibition was evaluated at 10: complete inhibition), and the results shown in Table 3 were obtained.

【0079】[0079]

【表16】[Table 16]

【0080】[0080]

【表17】[Table 17]

【0081】[0081]

【表18】[Table 18]

【0082】[0082]

【表19】[Table 19]

【0083】[0083]

【表20】[Table 20]

【0084】[0084]

【表21】[Table 21]

【0085】[0085]

【表22】[Table 22]

【0086】試験例21/10,000アールポットに
畑作土壌をつめ、コムギ及びワイルドオートの種子を各
々別のポットに播種した。その後、コムギが1.8〜2
.5葉期、ワイルドオートが1.1〜1.5葉期に達し
たとき、本発明除草剤の水和剤を所定量となるように秤
量し、アール当り5リットルの水に希釈した。更にその
水溶液に農業展着剤を0.2%となるように加えて、小
型スプレーで茎葉処理した。処理後20〜23日目に各
種植物の成育状態を肉眼で観察調査をおこない、前記試
験例1と同様の方法で生育抑制程度を評価し、第4表の
結果を得た。
Test Example 2 A 1/10,000 are pot was filled with field soil, and wheat and wild oat seeds were sown in separate pots. After that, wheat is 1.8-2
.. When the wild oats reached the 5-leaf stage and the 1.1-1.5 leaf stage, a predetermined amount of the wetting agent of the herbicide of the present invention was weighed out and diluted with 5 liters of water per are. Further, an agricultural spreading agent was added to the aqueous solution at a concentration of 0.2%, and the foliage was treated with a small sprayer. 20 to 23 days after the treatment, the growth status of each plant was visually observed and the degree of growth inhibition was evaluated using the same method as in Test Example 1, and the results shown in Table 4 were obtained.

【0087】[0087]

【表23】[Table 23]

【0088】試験例31/10,000アールポットに
畑作土壌をつめ、テンサイ(シュガービート)の種子を
播種した。その後テンサイが2葉期に達したとき、本発
明除草剤の水和剤を所定量となるように秤量し、アール
当り5リットルの水に希釈した。更にその水溶液に農業
展着剤を0.2%となるように加えて、小型スプレーで
茎葉処理した。処理後18日目に各種植物の生育状態を
肉眼で観察調査をおこない、前記試験例1と同様の方法
で生育抑制程度を評価し、第5表の結果を得た。
Test Example 3 Upland soil was filled in a 1/10,000 are pot, and sugar beet (sugar beet) seeds were sown. Thereafter, when the sugar beet reached the two-leaf stage, a predetermined amount of the hydrating agent of the herbicide of the present invention was weighed out and diluted with 5 liters of water per area. Further, an agricultural spreading agent was added to the aqueous solution at a concentration of 0.2%, and the foliage was treated with a small sprayer. On the 18th day after the treatment, the growth conditions of the various plants were observed and investigated with the naked eye, and the degree of growth inhibition was evaluated using the same method as in Test Example 1, and the results shown in Table 5 were obtained.

【0089】[0089]

【表24】[Table 24]

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】  一般式(I) 【化1】 (式中、R1はシクロアルキル基、アルコキシアルキル
基、置換されてもよいフェニル基、置換されてもよいピ
リジル基、置換されてもよいチエニル基、置換されても
よいフリル基、置換されてもよいピラゾリル基又は置換
されてもよいピラジニル基であり、R2はアルキル基、
ハロアルキル基、シクロアルキル基、フェニル基又はベ
ンジル基であり、R3は水素原子、ハロゲン原子、アル
キル基又はハロアルキル基であり、X及びYは各々独立
してハロゲン原子、アルキル基、アルコキシ基又はハロ
アルコキシ基であり、Aは=CH−又は=N−である)
で表わされるスルホニル尿素系化合物又はそれらの塩。
Claim 1: General formula (I) [Formula 1] (wherein R1 is a cycloalkyl group, an alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted thienyl group) group, an optionally substituted furyl group, an optionally substituted pyrazolyl group, or an optionally substituted pyrazinyl group, and R2 is an alkyl group,
A haloalkyl group, a cycloalkyl group, a phenyl group, or a benzyl group, R3 is a hydrogen atom, a halogen atom, an alkyl group, or a haloalkyl group, and X and Y are each independently a halogen atom, an alkyl group, an alkoxy group, or a haloalkoxy and A is =CH- or =N-)
A sulfonylurea compound or a salt thereof.
【請求項2】  一般式(II) 【化2】 (式中、R1はシクロアルキル基、アルコキシアルキル
基、置換されてもよいフェニル基、置換されてもよいピ
リジル基、置換されてもよいチエニル基、置換されても
よいフリル基、置換されてもよいピラゾリル基又は置換
されてもよいピラジニル基であり、R2はアルキル基、
ハロアルキル基、シクロアルキル基、フェニル基又はベ
ンジル基であり、R3は水素原子、ハロゲン原子、アル
キル基又はハロアルキル基であり、Z1は−NH2基、
−NCO基又は−NHCO2R4基であり、R4はアル
キル基又はアリール基である)で表わされる置換ピリジ
ン系化合物と、一般式(III) 【化3】 (式中、X及びYは各々独立してハロゲン原子、アルキ
ル基、アルコキシ基又はハロアルコキシ基であり、Aは
=CH−又は=N−であり、Z2はZ1が−NCO基又
は−NHCO2R4基の場合−NH2基であり、Z1が
−NH2基の場合−NCO基又は−NHCO2R4基で
あり、R4は前述の通りである)で表わされるピリミジ
ン系化合物とを反応させることを特徴とする、一般式(
I) 【化1】 (式中、R1、R2、R3、X、Y及びAは前述の通り
である)で表わされるスルホニル尿素系化合物又はそれ
らの塩の製造方法。
[Claim 2] General formula (II) [Formula 2] (wherein, R1 is a cycloalkyl group, an alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted thienyl group) group, an optionally substituted furyl group, an optionally substituted pyrazolyl group, or an optionally substituted pyrazinyl group, and R2 is an alkyl group,
is a haloalkyl group, cycloalkyl group, phenyl group or benzyl group, R3 is a hydrogen atom, halogen atom, alkyl group or haloalkyl group, Z1 is -NH2 group,
-NCO group or -NHCO2R4 group, R4 is an alkyl group or aryl group), and a substituted pyridine compound represented by the general formula (III) [Formula 3] (wherein, X and Y are each independently It is a halogen atom, an alkyl group, an alkoxy group or a haloalkoxy group, A is =CH- or =N-, Z2 is a -NH2 group when Z1 is -NCO group or -NHCO2R4 group, and Z1 is -NH2 In the case of the group, it is a -NCO group or -NHCO2R4 group, and R4 is as described above).
I) A method for producing a sulfonylurea compound represented by the following formula (wherein R1, R2, R3, X, Y and A are as described above) or a salt thereof.
【請求項3】  一般式(I) 【化1】 (式中、R1はシクロアルキル基、アルコキシアルキル
基、置換されてもよいフェニル基、置換されてもよいピ
リジル基、置換されてもよいチエニル基、置換されても
よいフリル基、置換されてもよいピラゾリル基又は置換
されてもよいピラジニル基であり、R2はアルキル基、
ハロアルキル基、シクロアルキル基、フェニル基又はベ
ンジル基であり、R3は水素原子、ハロゲン原子、アル
キル基又はハロアルキル基であり、X及びYは各々独立
してハロゲン原子、アルキル基、アルコキシ基又はハロ
アルコキシ基であり、Aは=CH−又は=N−である)
で表わされるスルホニル尿素系化合物又はそれらの塩を
有効成分とすることを特徴とする除草剤。
3. General formula (I) [Formula 1] (wherein, R1 is a cycloalkyl group, an alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted thienyl group) group, an optionally substituted furyl group, an optionally substituted pyrazolyl group, or an optionally substituted pyrazinyl group, and R2 is an alkyl group,
A haloalkyl group, a cycloalkyl group, a phenyl group, or a benzyl group, R3 is a hydrogen atom, a halogen atom, an alkyl group, or a haloalkyl group, and X and Y are each independently a halogen atom, an alkyl group, an alkoxy group, or a haloalkoxy and A is =CH- or =N-)
A herbicide characterized by containing a sulfonylurea compound represented by the following or a salt thereof as an active ingredient.
【請求項4】  一般式(II−1) 【化4】 (式中、R1はシクロアルキル基、アルコキシアルキル
基、置換されてもよいフェニル基、置換されてもよいピ
リジル基、置換されてもよいチエニル基、置換されても
よいフリル基、置換されてもよいピラゾリル基又は置換
されてもよいピラジニル基であり、R2はアルキル基、
ハロアルキル基、シクロアルキル基、フェニル基又はベ
ンジル基であり、R3は水素原子、ハロゲン原子、アル
キル基又はハロアルキル基である)で表わされる置換ピ
リジン系化合物。
[Claim 4] General formula (II-1) [Formula 4] (wherein, R1 is a cycloalkyl group, an alkoxyalkyl group, an optionally substituted phenyl group, an optionally substituted pyridyl group, an optionally substituted pyridyl group, or an optionally substituted pyridyl group) a thienyl group, an optionally substituted furyl group, an optionally substituted pyrazolyl group, or an optionally substituted pyrazinyl group, R2 is an alkyl group,
A substituted pyridine compound represented by a haloalkyl group, a cycloalkyl group, a phenyl group, or a benzyl group, and R3 is a hydrogen atom, a halogen atom, an alkyl group, or a haloalkyl group.
JP10062891A 1991-02-05 1991-02-05 Sulfonylurea compound, its production and herbicide containing the same Pending JPH04253974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10062891A JPH04253974A (en) 1991-02-05 1991-02-05 Sulfonylurea compound, its production and herbicide containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10062891A JPH04253974A (en) 1991-02-05 1991-02-05 Sulfonylurea compound, its production and herbicide containing the same

Publications (1)

Publication Number Publication Date
JPH04253974A true JPH04253974A (en) 1992-09-09

Family

ID=14279105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10062891A Pending JPH04253974A (en) 1991-02-05 1991-02-05 Sulfonylurea compound, its production and herbicide containing the same

Country Status (1)

Country Link
JP (1) JPH04253974A (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR27073A (en) * 1992-03-10 1994-10-12 Ishihara Sangyo Kaisha The substituted pyridinsulfonamide compound or salt is the process for the preparation of this compound or salt, and the herbicide containing this compound or salt.
US7196089B2 (en) 2003-01-29 2007-03-27 Asterand Uk Limited EP4 receptor antagonists
US7417068B2 (en) 2003-10-16 2008-08-26 Asterand Uk Limited EP4 receptor antagonists
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US7943582B2 (en) 2006-12-04 2011-05-17 Mitsubishi Tanabe Pharma Corporation Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate
US7943788B2 (en) 2003-08-01 2011-05-17 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US8853385B2 (en) 2008-01-17 2014-10-07 Mitsubishi Tanabe Pharma Corporation Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
US9024009B2 (en) 2007-09-10 2015-05-05 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US9174971B2 (en) 2009-10-14 2015-11-03 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
US10544135B2 (en) 2011-04-13 2020-01-28 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
US10617668B2 (en) 2010-05-11 2020-04-14 Janssen Pharmaceutica Nv Pharmaceutical formulations
US11207337B2 (en) 2015-09-15 2021-12-28 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US11576894B2 (en) 2009-07-08 2023-02-14 Janssen Pharmaceutica Nv Combination therapy for the treatment of diabetes

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR27073A (en) * 1992-03-10 1994-10-12 Ishihara Sangyo Kaisha The substituted pyridinsulfonamide compound or salt is the process for the preparation of this compound or salt, and the herbicide containing this compound or salt.
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US8106051B2 (en) 2001-09-14 2012-01-31 Shionogi & Co., Ltd. Utilities of amide compounds
US7196089B2 (en) 2003-01-29 2007-03-27 Asterand Uk Limited EP4 receptor antagonists
US7507754B2 (en) 2003-01-29 2009-03-24 Asterand Uk Limited EP4 receptor antagonists
US7528157B2 (en) 2003-01-29 2009-05-05 Asterand Uk Limited EP4 receptor antagonists
US7858644B2 (en) 2003-01-29 2010-12-28 Asterand Uk Limited EP4 receptor antagonists
US8202984B2 (en) 2003-08-01 2012-06-19 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US8222219B2 (en) 2003-08-01 2012-07-17 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US7943788B2 (en) 2003-08-01 2011-05-17 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
US7569602B2 (en) 2003-10-16 2009-08-04 Asterand Uk Limited Furan derivatives as EP4 receptor antagonists
US7417068B2 (en) 2003-10-16 2008-08-26 Asterand Uk Limited EP4 receptor antagonists
US7943582B2 (en) 2006-12-04 2011-05-17 Mitsubishi Tanabe Pharma Corporation Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate
US8513202B2 (en) 2006-12-04 2013-08-20 Mitsubishi Tanabe Pharma Corporation Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
US9024009B2 (en) 2007-09-10 2015-05-05 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US8853385B2 (en) 2008-01-17 2014-10-07 Mitsubishi Tanabe Pharma Corporation Combination therapy comprising SGLT inhibitors and DPP4 inhibitors
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US11576894B2 (en) 2009-07-08 2023-02-14 Janssen Pharmaceutica Nv Combination therapy for the treatment of diabetes
US9174971B2 (en) 2009-10-14 2015-11-03 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
US10617668B2 (en) 2010-05-11 2020-04-14 Janssen Pharmaceutica Nv Pharmaceutical formulations
US10544135B2 (en) 2011-04-13 2020-01-28 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of SGLT2
US9035044B2 (en) 2011-05-09 2015-05-19 Janssen Pharmaceutica Nv L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
US11207337B2 (en) 2015-09-15 2021-12-28 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders

Similar Documents

Publication Publication Date Title
JPH04253974A (en) Sulfonylurea compound, its production and herbicide containing the same
KR20040010775A (en) Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators
KR20040065279A (en) Substituted phenyl derivatives
JPH0660173B2 (en) N-[(4,6-dimethoxypyrimidin-2-yl) aminocarbonyl] -3-trifluoromethylpyridine-2-sulfonamide or a salt thereof, a method for producing them and a herbicide containing them
RU2707086C1 (en) Pyrazole or salt thereof and method of producing, herbicidal composition and use thereof
EP0451468B2 (en) Substituted pyridinesulfonamide compounds, herbicidal compositions containing them, and process for their production
JPH10501525A (en) Nitrogen-substituted phenylsulfonylureas, their preparation and use as herbicides and plant growth regulators
TW201002207A (en) Selected salts of 3-(5,6-dihydro-1,4,2-dioxazin-3-yl)-N-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]pyridine-2-sulfonamide, processes for their preparation and their use as herbicides and plant growth regulators
JPH0586055A (en) Substituted pyridinesulfonamide-based compound, its production and herbicide containing the same compound
CA2657598A1 (en) Substituted furyl sulfonylamino(thio)carbonyl triazoline(thi)ones
JPH04257580A (en) Sulfonamide-based compound, its production and herbicide containing the same compound
US5457084A (en) Substituted pyridinesulfonamide compound or its salt, process for preparing the same, and herbicide containing the same
JPH10501214A (en) Formylaminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
US4790869A (en) Sulfonamide compounds and salts thereof, herbicidal compositions containing them
KR20140084204A (en) Substituted 4-cyano-3-phenyl-4-(pyridin-3-yl)butanoates, processes for preparation thereof and use thereof as herbicides and plant growth regulators
JP2689093B2 (en) Substituted pyridine sulfonamide compounds, herbicides containing them and method for producing these compounds
JP2567353B2 (en) Substituted pyridine compound
JP2506063B2 (en) Substituted pyridine compound
JPH0687855A (en) Substituted pyridinesulfonamide compound, its production and herbicide containing the same
EP0562731A1 (en) Substituted pyridinesulfonamide compounds or their salts, process for preparing the same, and herbicides containing the same
JPH0649040A (en) Substituted azine
JPH0912553A (en) Substituted pyridine-based compound
JPH0688997B2 (en) Sulfonamide compounds and salts thereof, herbicidal compositions containing them, and methods for producing the same
JP4467239B2 (en) Substituted benzoylcyclohexenones and their use as herbicides
JPH06234763A (en) Cyclic amide compound, its production and herbicidal composition containing the same